-
1
-
-
70350144293
-
Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production
-
Byrd, M.S., I. Sadovskaya, E. Vinogradov, H. Lu, A.B. Sprinkle, S.H. Richardson, L. Ma, B. Ralston, M.R. Parsek, E.M. Anderson, et al. 2009. Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlapping roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol. Microbiol. 73:622-638. http://dx.doi.org/ 10.1111/j.1365-2958.2009.06795.x
-
(2009)
Mol. Microbiol
, vol.73
, pp. 622-638
-
-
Byrd, M.S.1
Sadovskaya, I.2
Vinogradov, E.3
Lu, H.4
Sprinkle, A.B.5
Richardson, S.H.6
Ma, L.7
Ralston, B.8
Parsek, M.R.9
Anderson, E.M.10
-
2
-
-
40649112565
-
Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis
-
Campodónico, V.L., M. Gadjeva, C. Paradis-Bleau, A. Uluer, and G.B. Pier. 2008. Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis. Trends Mol. Med. 14:120-133. http://dx.doi.org/ 10.1016/j.molmed.2008.01.002
-
(2008)
Trends Mol. Med.
, vol.14
, pp. 120-133
-
-
Campodónico, V.L.1
Gadjeva, M.2
Paradis-Bleau, C.3
Uluer, A.4
Pier, G.B.5
-
3
-
-
47049095809
-
Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
-
Clunes, M.T., and R.C. Boucher. 2007. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder. Drug Discov. Today Dis. Mech. 4:63-72. http://dx.doi.org/10.1016/j.ddmec.2007.09.001
-
(2007)
Drug Discov. Today Dis. Mech
, vol.4
, pp. 63-72
-
-
Clunes, M.T.1
Boucher, R.C.2
-
4
-
-
84859620802
-
Cystic fibrosis: a mucosal immunodeficiency syndrome
-
Cohen, T.S., and A. Prince. 2012. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat. Med. 18:509-519. http://dx.doi.org/ 10.1038/nm.2715
-
(2012)
Nat. Med.
, vol.18
, pp. 509-519
-
-
Cohen, T.S.1
Prince, A.2
-
5
-
-
84864291211
-
Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening
-
DiGiandomenico, A., P. Warrener, M. Hamilton, S. Guillard, P. Ravn, R. Minter, M. Margarita Camara, V. Venkatraman, R.S. MacGill, J. Lin, et al. 2012. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. J. Exp. Med. 209:1273-1287.
-
(2012)
J. Exp. Med.
, vol.209
, pp. 1273-1287
-
-
DiGiandomenico, A.1
Warrener, P.2
Hamilton, M.3
Guillard, S.4
Ravn, P.5
Minter, R.6
Margarita Camara, M.7
Venkatraman, V.8
MacGill, R.S.9
Lin, J.10
-
6
-
-
34249864458
-
Predictors of mortality in adults with cystic fibrosis
-
Courtney, J.M., J. Bradley, J. Mccaughan, T.M. O'Connor, C. Shortt, C.P. Bredin, I. Bradbury, and J.S. Elborn. 2007. Predictors of mortality in adults with cystic fibrosis. Pediatr. Pulmonol. 42:525-532. http://dx.doi.org/10.1002/ppul.20619
-
(2007)
Pediatr. Pulmonol.
, vol.42
, pp. 525-532
-
-
Courtney, J.M.1
Bradley, J.2
Mccaughan, J.3
O'Connor, T.M.4
Shortt, C.5
Bredin, C.P.6
Bradbury, I.7
Elborn, J.S.8
-
7
-
-
79953700578
-
New horizons in the treatment of cystic fibrosis
-
Cuthbert, A.W. 2011. New horizons in the treatment of cystic fibrosis. Br. J. Pharmacol. 163:173-183. http://dx.doi.org/10.1111/j.1476-5381.2010.01137.x
-
(2011)
Br. J. Pharmacol.
, vol.163
, pp. 173-183
-
-
Cuthbert, A.W.1
-
8
-
-
70349223856
-
Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion
-
Garcia, M.A., N. Yang, and P.M. Quinton. 2009. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J. Clin. Invest. 119:2613-2622. http://dx.doi.org/10.1172/JCI38662
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 2613-2622
-
-
Garcia, M.A.1
Yang, N.2
Quinton, P.M.3
-
9
-
-
79961042398
-
Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture
-
Ghafoor, A., I.D. Hay, and B.H.A. Rehm. 2011. Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl. Environ. Microbiol. 77:5238-5246. http://dx.doi.org/10.1128/AEM.00637-11
-
(2011)
Appl. Environ. Microbiol.
, vol.77
, pp. 5238-5246
-
-
Ghafoor, A.1
Hay, I.D.2
Rehm, B.H.A.3
-
10
-
-
79953215718
-
Current status and future directions of gene and cell therapy for cystic fibrosis
-
Griesenbach, U., and E.W. Alton. 2011. Current status and future directions of gene and cell therapy for cystic fibrosis. BioDrugs. 25:77-88. http://dx.doi.org/10.2165/11586960-000000000-00000
-
(2011)
BioDrugs
, vol.25
, pp. 77-88
-
-
Griesenbach, U.1
Alton, E.W.2
-
11
-
-
33846117944
-
Cystic fibrosis mouse models
-
Guilbault, C., Z. Saeed, G.P. Downey, and D. Radzioch. 2007. Cystic fibrosis mouse models. Am. J. Respir. Cell Mol. Biol. 36:1-7. http:// dx.doi.org/10.1165/rcmb.2006-0184TR
-
(2007)
Am. J. Respir. Cell Mol. Biol.
, vol.36
, pp. 1-7
-
-
Guilbault, C.1
Saeed, Z.2
Downey, G.P.3
Radzioch, D.4
-
12
-
-
84864313785
-
Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype
-
Gustafsson, J.K. A., Ermund, D., Ambort, M.E.V., Johansson, H.E., Nilsson, K., Thorell, H., Hebert, H., Sjövall, and G.C. Hansson. 2012. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J. Exp. Med. 209:1263-1272.
-
(2012)
J. Exp. Med.
, vol.209
, pp. 1263-1272
-
-
Gustafsson, J.K.1
Ermund, A.2
Ambort, D.3
Johansson, M.E.V.4
Nilsson, H.E.5
Thorell, K.6
Hebert, H.7
Sjövall, H.8
Hansson, G.C.9
-
13
-
-
71549131283
-
Pseudomonas aeruginosa: a formidable and ever-present adversary
-
Kerr, K.G., and A.M. Snelling. 2009. Pseudomonas aeruginosa: a formidable and ever-present adversary. J. Hosp. Infect. 73:338-344. http://dx.doi.org/10.1016/j.jhin.2009.04.020
-
(2009)
J. Hosp. Infect
, vol.73
, pp. 338-344
-
-
Kerr, K.G.1
Snelling, A.M.2
-
14
-
-
0023739855
-
Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4
-
Kocharova, N.A., Y.A. Knirel, A.S. Shashkov, N.K. Kochetkov, and G.B. Pier. 1988. Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4. J. Biol. Chem. 263:11291-11295.
-
(1988)
J. Biol. Chem.
, vol.263
, pp. 11291-11295
-
-
Kocharova, N.A.1
Knirel, Y.A.2
Shashkov, A.S.3
Kochetkov, N.K.4
Pier, G.B.5
-
15
-
-
72449194729
-
Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia
-
Koh, A.Y., G.P. Priebe, C. Ray, N. Van Rooijen, and G.B. Pier. 2009. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect. Immun. 77:5300-5310. http://dx.doi.org/10.1128/IAI.00501-09
-
(2009)
Infect. Immun.
, vol.77
, pp. 5300-5310
-
-
Koh, A.Y.1
Priebe, G.P.2
Ray, C.3
Van Rooijen, N.4
Pier, G.B.5
-
16
-
-
0034099054
-
The effect of alginate on the invasion of cystic fibrosis respiratory epithelial cells by clinical isolates of Pseudomonas aeruginosa
-
Massengale, A.R., F.J. Quinn, A. Williams, S. Gallagher, and S.C. Aronoff. 2000. The effect of alginate on the invasion of cystic fibrosis respiratory epithelial cells by clinical isolates of Pseudomonas aeruginosa. Exp. Lung Res. 26:163-178. http://dx.doi.org/10.1080/019021400269853
-
(2000)
Exp. Lung Res.
, vol.26
, pp. 163-178
-
-
Massengale, A.R.1
Quinn, F.J.2
Williams, A.3
Gallagher, S.4
Aronoff, S.C.5
-
17
-
-
84862776813
-
on behalf of AREST CF. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT
-
Mott, L.S., J. Park, C.P. Murray, C.L. Gangell, N.H. de Klerk, P.J. Robinson, C.F. Robertson, S.C. Ranganathan, P.D. Sly, and S.M. Stick; on behalf of AREST CF. 2012. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax. 67:509-516. http://dx.doi.org/ 10.1136/thoraxjnl-2011-200912
-
(2012)
Thorax
, vol.67
, pp. 509-516
-
-
Mott, L.S.1
Park, J.2
Murray, C.P.3
Gangell, C.L.4
de Klerk, N.H.5
Robinson, P.J.6
Robertson, C.F.7
Ranganathan, S.C.8
Sly, P.D.9
Stick, S.M.10
-
18
-
-
77954644239
-
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
-
Oliver, A., and A. Mena. 2010. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance. Clin. Microbiol. Infect. 16:798-808. http://dx.doi.org/10.1111/j.1469-0691.2010.03250.x
-
(2010)
Clin. Microbiol. Infect.
, vol.16
, pp. 798-808
-
-
Oliver, A.1
Mena, A.2
-
19
-
-
79952779452
-
The ?F508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs
-
Ostedgaard, L.S., D.K. Meyerholz, J.H. Chen, A.A. Pezzulo, P.H. Karp, T. Rokhlina, S.E. Ernst, R.A. Hanfland, L.R. Reznikov, P.S. Ludwig, et al. 2011. The ?F508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs. Sci. Transl. Med. 3:ra24. http://dx.doi.org/10.1126/scitranslmed.3001868
-
(2011)
Sci. Transl. Med.
, vol.3
-
-
Ostedgaard, L.S.1
Meyerholz, D.K.2
Chen, J.H.3
Pezzulo, A.A.4
Karp, P.H.5
Rokhlina, T.6
Ernst, S.E.7
Hanfland, R.A.8
Reznikov, L.R.9
Ludwig, P.S.10
-
20
-
-
0023220464
-
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older, non-colonized cystic fibrosis patients
-
Pier, G.B., J.M. Saunders, P. Ames, M.S. Edwards, H. Auerbach, J. Goldfarb, D.P. Speert, and S. Hurwitch. 1987. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older, non-colonized cystic fibrosis patients. N. Engl. J. Med. 317:793-798. http://dx.doi.org/10.1056/ NEJM198709243171303
-
(1987)
N. Engl. J. Med.
, vol.317
, pp. 793-798
-
-
Pier, G.B.1
Saunders, J.M.2
Ames, P.3
Edwards, M.S.4
Auerbach, H.5
Goldfarb, J.6
Speert, D.P.7
Hurwitch, S.8
-
21
-
-
6344275530
-
Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains
-
Pier, G.B., D. Boyer, M. Preston, F.T. Coleman, N. Llosa, S. Mueschenborn-Koglin, C. Theilacker, H. Goldenberg, J. Uchin, G.P. Priebe, et al. 2004. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J. Immunol. 173:5671-5678.
-
(2004)
J. Immunol.
, vol.173
, pp. 5671-5678
-
-
Pier, G.B.1
Boyer, D.2
Preston, M.3
Coleman, F.T.4
Llosa, N.5
Mueschenborn-Koglin, S.6
Theilacker, C.7
Goldenberg, H.8
Uchin, J.9
Priebe, G.P.10
-
22
-
-
48149090717
-
Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis
-
Quinton, P.M. 2008. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet. 372:415-417. http://dx.doi.org/10.1016/S0140-6736(08)61162-9
-
(2008)
Lancet
, vol.372
, pp. 415-417
-
-
Quinton, P.M.1
-
23
-
-
80455162465
-
VX08-770-102 Study Group. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
-
Ramsey, B.W., J. Davies, N.G. McElvaney, E. Tullis, S.C. Bell, P. Dřevínek, M. Griese, E.F. McKone, C.E. Wainwright, M.W. Konstan, et al; VX08-770-102 Study Group. 2011. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N. Engl. J. Med. 365:1663-1672. http://dx.doi.org/10 .1056/NEJMoa1105185
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 1663-1672
-
-
Ramsey, B.W.1
Davies, J.2
McElvaney, N.G.3
Tullis, E.4
Bell, S.C.5
Dřevínek, P.6
Griese, M.7
McKone, E.F.8
Wainwright, C.E.9
Konstan, M.W.10
-
24
-
-
84861780622
-
Immune responses in cystic fibrosis: are they intrinsically defective? Am
-
Ratner, D., and C. Mueller. 2012. Immune responses in cystic fibrosis: are they intrinsically defective? Am. J. Respir. Cell Mol. Biol. 46:715-722. http://dx.doi.org/10.1165/rcmb.2011-0399RT
-
(2012)
J. Respir. Cell Mol. Biol.
, vol.46
, pp. 715-722
-
-
Ratner, D.1
Mueller, C.2
-
25
-
-
84862317515
-
Hypertonic saline in treatment of pulmonary disease in cystic fibrosis
-
Reeves, E.P., K. Molloy, K. Pohl, and N.G. McElvaney. 2012. Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. ScientificWorldJournal. 2012:465230. http://dx.doi.org/10.1100/2012/465230
-
(2012)
ScientificWorldJournal
, vol.2012
, pp. 465230
-
-
Reeves, E.P.1
Molloy, K.2
Pohl, K.3
McElvaney, N.G.4
-
26
-
-
34147134534
-
Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor
-
Reiniger, N., M.M. Lee, F.T. Coleman, C. Ray, D.E. Golan, and G.B. Pier. 2007. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor. Infect. Immun. 75:1598-1608. http://dx.doi.org/10.1128/ IAI.01980-06
-
(2007)
Infect. Immun.
, vol.75
, pp. 1598-1608
-
-
Reiniger, N.1
Lee, M.M.2
Coleman, F.T.3
Ray, C.4
Golan, D.E.5
Pier, G.B.6
-
27
-
-
80052689527
-
Healthrelated quality of life in cystic fibrosis
-
Royce, F.H., and J.C. Carl. 2011. Healthrelated quality of life in cystic fibrosis. Curr. Opin. Pediatr. 23:535-540. http://dx.doi.org/10.1097/MOP.0b013e32834a7829
-
(2011)
Curr. Opin. Pediatr
, vol.23
, pp. 535-540
-
-
Royce, F.H.1
Carl, J.C.2
-
28
-
-
77956379893
-
Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis
-
Sun, X., H. Sui, J.T. Fisher, Z. Yan, X. Liu, H.J. Cho, N.S. Joo, Y. Zhang, W. Zhou, Y. Yi, et al. 2010. Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 120:3149-3160. http://dx.doi.org/10.1172/JCI43052
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 3149-3160
-
-
Sun, X.1
Sui, H.2
Fisher, J.T.3
Yan, Z.4
Liu, X.5
Cho, H.J.6
Joo, N.S.7
Zhang, Y.8
Zhou, W.9
Yi, Y.10
-
29
-
-
48749109290
-
Pyogenic bacterial infections in humans with MyD88 deficiency
-
von Bernuth, H., C. Picard, Z. Jin, R. Pankla, H. Xiao, C.-L. Ku, M. Chrabieh, I.B. Mustapha, P. Ghandil, Y. Camcioglu, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science. 321:691-696. http://dx.doi.org/10.1126/science.1158298
-
(2008)
Science
, vol.321
, pp. 691-696
-
-
von Bernuth, H.1
Picard, C.2
Jin, Z.3
Pankla, R.4
Xiao, H.5
Ku, C.-L.6
Chrabieh, M.7
Mustapha, I.B.8
Ghandil, P.9
Camcioglu, Y.10
-
30
-
-
79958069364
-
The airway microbiome in cystic fibrosis and implications for treatment
-
Zemanick, E.T., S.D. Sagel, and J.K. Harris. 2011. The airway microbiome in cystic fibrosis and implications for treatment. Curr. Opin. Pediatr. 23:319-324. http://dx.doi.org/10.1097/ MOP.0b013e32834604f2
-
(2011)
Curr. Opin. Pediatr.
, vol.23
, pp. 319-324
-
-
Zemanick, E.T.1
Sagel, S.D.2
Harris, J.K.3
-
31
-
-
0028557095
-
Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR
-
Zhou, L., C.R. Dey, S.E. Wert, M.D. DuVall, R.A. Frizzell, and J.A. Whitsett. 1994. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science. 266:1705-1708. http://dx.doi.org/10.1126/science.7527588
-
(1994)
Science
, vol.266
, pp. 1705-1708
-
-
Zhou, L.1
Dey, C.R.2
Wert, S.E.3
DuVall, M.D.4
Frizzell, R.A.5
Whitsett, J.A.6
|